The drug treatment of premature ejaculation

The management recommendation for both acquired premature ejaculation (APE) and lifelong PE (LPE) are similar, such as a behavioral/psychotherapy, a pharmacotherapy and a combination of these treatments. For the drug treatment for PE, gold standard is selective serotonin reuptake inhibitors (SSRIs)...

Descripción completa

Detalles Bibliográficos
Autor principal: Hisasue, Shin-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001998/
https://www.ncbi.nlm.nih.gov/pubmed/27652221
http://dx.doi.org/10.21037/tau.2016.06.10
_version_ 1782450501986549760
author Hisasue, Shin-ichi
author_facet Hisasue, Shin-ichi
author_sort Hisasue, Shin-ichi
collection PubMed
description The management recommendation for both acquired premature ejaculation (APE) and lifelong PE (LPE) are similar, such as a behavioral/psychotherapy, a pharmacotherapy and a combination of these treatments. For the drug treatment for PE, gold standard is selective serotonin reuptake inhibitors (SSRIs) including dapoxetine or paroxetine. The drug treatment for PE is still developing and some new promising therapeutic options have been proposed. Topical anesthetics, tramadol, and alpha-1 blockers will be the next strategies of the drug treatment for PE in the future.
format Online
Article
Text
id pubmed-5001998
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-50019982016-09-20 The drug treatment of premature ejaculation Hisasue, Shin-ichi Transl Androl Urol Review Article The management recommendation for both acquired premature ejaculation (APE) and lifelong PE (LPE) are similar, such as a behavioral/psychotherapy, a pharmacotherapy and a combination of these treatments. For the drug treatment for PE, gold standard is selective serotonin reuptake inhibitors (SSRIs) including dapoxetine or paroxetine. The drug treatment for PE is still developing and some new promising therapeutic options have been proposed. Topical anesthetics, tramadol, and alpha-1 blockers will be the next strategies of the drug treatment for PE in the future. AME Publishing Company 2016-08 /pmc/articles/PMC5001998/ /pubmed/27652221 http://dx.doi.org/10.21037/tau.2016.06.10 Text en 2016 Translational Andrology and Urology. All rights reserved.
spellingShingle Review Article
Hisasue, Shin-ichi
The drug treatment of premature ejaculation
title The drug treatment of premature ejaculation
title_full The drug treatment of premature ejaculation
title_fullStr The drug treatment of premature ejaculation
title_full_unstemmed The drug treatment of premature ejaculation
title_short The drug treatment of premature ejaculation
title_sort drug treatment of premature ejaculation
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001998/
https://www.ncbi.nlm.nih.gov/pubmed/27652221
http://dx.doi.org/10.21037/tau.2016.06.10
work_keys_str_mv AT hisasueshinichi thedrugtreatmentofprematureejaculation
AT hisasueshinichi drugtreatmentofprematureejaculation

Ejemplares similares